AMY NAGAR: Open Payments
NPI 1437624723 · EUCLID, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 36 payments from 12 companies in 2025. Trend: 2023 $908 · 2024 $975 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $129 |
| E.R. Squibb & Sons, L.L.C. | 7 | $121 |
| Esperion Therapeutics, Inc. | 5 | $92 |
| Novo Nordisk Inc | 3 | $80 |
| Amgen Inc. | 3 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $42 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| AtriCure, Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
Products named: LEQVIO, NEXLETOL, Wegovy, ELIQUIS, REPATHA, CAMZYOS, JARDIANCE, ONPATTRO.
Industry payments across OH — which companies pay providers there.
